Treatment Satisfaction and Quality of Life in Patients with Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

被引:0
|
作者
Kosch, Katherine J. [1 ]
Ye, Xiaolan [1 ]
Xu, Yanqing [1 ]
McKnight-Smith, Gina [1 ]
Ando, Masakazu [2 ]
Dobrescu, Rachel [3 ]
Morlock, Amy [3 ]
Morlock, Robert [4 ]
Rooker, Ceciel [5 ]
Lacy, Brian [6 ]
机构
[1] AbbVie Inc, N Chicago, IL USA
[2] Ironwood Pharmaceut, Boston, MA USA
[3] Acumen Hlth Res Inst, Ann Arbor, MI USA
[4] YourCareChoice, Ann Arbor, MI USA
[5] Int Fdn Gastrointestinal Disorders, Milwaukee, WI USA
[6] Mayo Clin, Jacksonville, FL USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S623
引用
收藏
页码:S457 / S458
页数:2
相关论文
共 50 条
  • [11] Constipation Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation
    Shah, Eric D.
    Almario, Christopher
    Spiegel, Brennan M.
    Chey, William D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S241 - S242
  • [12] Health-Related Quality of Life Associated with Chronic Constipation or Irritable Bowel Syndrome with Constipation
    Xu, Yaping
    Lasch, Karen
    Wagner, Samuel
    Chapnick, Jonathan
    Dabbous, Omar
    GASTROENTEROLOGY, 2009, 136 (05) : A485 - A485
  • [13] Effect of stool consistency on bowel movement satisfaction in patients with Irritable Bowel Syndrome with constipation or chronic idiopathic constipation: results from the CONTOR study
    Taylor, D. C. A.
    Abel, J. L.
    Doshi, J. A.
    Martin, C.
    Hunter, A. Goolsby
    Essoi, B.
    Korrer, S.
    Carson, R. T.
    Reasner, D. S.
    Chey, W. D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [14] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Maria I. Vazquez-Roque
    Ernest P. Bouras
    Advances in Therapy, 2013, 30 : 203 - 211
  • [15] The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation
    Jeremy D. Gale
    Advances in Therapy, 2009, 26 : 519 - 530
  • [16] Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
    Sayuk, Gregory S.
    Waldman, Scott A.
    Brenner, Darren M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (4S): : S6 - S13
  • [17] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
    Vazquez-Roque, Maria I.
    Bouras, Ernest P.
    ADVANCES IN THERAPY, 2013, 30 (03) : 203 - 211
  • [18] Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
    Brenner, Darren M.
    Harris, Lucinda A.
    Chang, Christopher H.
    Waldman, Scott A.
    Poppers, David M.
    Kassebaum-Ladewski, Amy
    Sayuk, Gregory S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (4S): : S21 - S26
  • [19] Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
    Kassebaum-Ladewski, Amy
    Poppers, David M.
    Brenner, Darren M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (4S): : S14 - S20
  • [20] The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation
    Gale, Jeremy D.
    ADVANCES IN THERAPY, 2009, 26 (05) : 519 - 530